← Evidence map

ReviewBioscience reports2019

Engineering anti-cancer nanovaccine based on antigen cross-presentation.

Vaishnavi U Warrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31652460